Position in CYTK
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$12,096
+$2,737 QoQ
Shares Held
142
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#411
of 477 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in CYTK Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Sherman Asset Management, Inc. holds $16,611 across 2 Biotechnology names. CYTK ranks #1 (72.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CYTK |
Cytokinetics Inc
This page
|
142 | $12,096 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
15 | $4,515 |
All Filings in CYTK
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,096 | 142 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $9,359 | 142 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $9,022 | 142 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $7,804 | 142 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $4,691 | 142 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $5,706 | 142 | Shares | Sole | 2025-04-14 | |
| 2024-12-31 | $6,679 | 142 | Shares | Sole | 2025-02-05 | |
| No filing history on record for this holder in this stock. | ||||||